Strata Critical Medical, Inc. (SRTA)
NASDAQ: SRTA · Real-Time Price · USD
4.930
+0.120 (2.49%)
At close: Jan 2, 2026, 4:00 PM EST
4.820
-0.110 (-2.23%)
After-hours: Jan 2, 2026, 7:43 PM EST
Strata Critical Medical Market Cap
Strata Critical Medical has a market cap or net worth of $425.79 million as of January 2, 2026. Its market cap has increased by 34.58% in one year.
Market Cap
425.79M
Enterprise Value
353.34M
1-Year Change
34.58%
Ranking
Category
Stock Price
$4.93
Market Cap Chart
Since November 5, 2019, Strata Critical Medical's market cap has increased from $335.16M to $425.79M, an increase of 27.04%. That is a compound annual growth rate of 3.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 415.42M | 24.81% |
| Dec 31, 2024 | 332.83M | 26.33% |
| Dec 29, 2023 | 263.46M | 2.70% |
| Dec 30, 2022 | 256.52M | -58.82% |
| Dec 31, 2021 | 622.98M | 63.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 966.79B |
| Johnson & Johnson | 498.51B |
| AbbVie | 406.04B |
| UnitedHealth Group | 300.88B |
| AstraZeneca | 287.28B |
| Novartis AG | 266.00B |
| Merck & Co. | 263.24B |
| Novo Nordisk | 227.63B |